Nutex Health, Inc.

80
Strong Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US67079U1088
USD
100.38
5.4 (5.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
875.00
479.00
247.00
219.00
331.00
1.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
875.00
479.00
247.00
219.00
331.00
1.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
22.00
19.00
16.00
12.00
6.00
0.00
General and Administration Expenses
168.00
58.00
36.00
18.00
5.00
3.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
599.00
342.00
248.00
223.00
157.00
5.00
Operating Profit (PBDIT) excl Other Income
275.00
137.00
-1.00
-4.00
173.00
-3.00
Other Income
-8.00
0.00
0.00
0.00
5.00
1.00
Operating Profit (PBDIT)
287.00
157.00
15.00
8.00
187.00
-1.00
Interest
22.00
19.00
16.00
12.00
6.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
20.00
18.00
17.00
13.00
7.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
244.00
109.00
-48.00
-419.00
169.00
-5.00
Provision for Tax
64.00
15.00
-5.00
13.00
0.00
0.00
Profit After Tax
70.00
52.00
-45.00
-424.00
132.00
-5.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
10.48
9.69
-10.39
-100.36
33.55
-175.80
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 82.36% vs 93.80% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 100.04% vs 10,768.25% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 11.51% vs 22.15% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 35.88% vs 213.78% in Dec 2024

Compare Profit and Loss Results of Nutex Health, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
875.00
18.00
857.00
4,761.11%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
875.00
18.00
857.00
4,761.11%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
22.00
0.00
22.00
0%
General and Administration Expenses
168.00
8.00
160.00
2,000.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
599.00
22.00
577.00
2,622.73%
Operating Profit (PBDIT) excl Other Income
275.00
-4.00
279.00
6,975.00%
Other Income
-8.00
0.00
-8.00
0%
Operating Profit (PBDIT)
287.00
-2.00
289.00
14,450.00%
Interest
22.00
0.00
22.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
20.00
1.00
19.00
1,900.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
244.00
-4.00
248.00
6,200.00%
Provision for Tax
64.00
0.00
64.00
0%
Profit After Tax
70.00
-4.00
74.00
1,850.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
10.4778
-2.9273
13.41
457.93%
Profit And Loss - Net Sales
Net Sales 875.26 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 82.36% vs 93.80% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 275.62 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 100.04% vs 10,768.25% in Dec 2024

Profit And Loss - Interest
Interest 22.23 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 11.51% vs 22.15% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 70.79 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 35.88% vs 213.78% in Dec 2024